INNOVAX-ND-ILT
Safe, effective protection in a single vaccine against three of the most infectious and commercially disruptive flock diseases – infectious laryngotracheitis, Newcastle disease and Marek’s disease.
Advantages
Unique 3-in-1 protection
Healthier, more productive birds
Superior, disease prevention
More efficient disease control
How It Works
Innovax-ND-ILT is administered in ovo or subcutaneously into day-old chicks at the hatchery to ensure the viability of this cell associated vaccine. HVT-based vaccines cannot spread bird-to-bird in the field so ensuring every chick or every hatching egg is properly vaccinated is the key to achieving uniform protection. Watch our Mode Of Action video to find out more.
1 please check local registration for indicated method of administration
No Need to Choose
Innovax-ND-ILT is a unique dual-construct herpesvirus of turkey (HVT) based vaccine that provides comprehensive protection against infectious laryngotracheitis (ILT), Newcastle disease (ND) and Marek’s disease (MD) in a single, 3-in-1 non-reactive vaccine. This means you no longer need to choose between diseases to protect against, one dose of Innovax-ND-ILT protects birds against both ILT and ND to significantly expand flock protection and improve efficiency.
Better Protection, Healthier Flocks
Innovax-ND-ILT reduces the threat from infectious diseases to improve overall flock health and productivity. Protection from a single dose minimizes operational disruption and provides a more dependable and complete flock performance whether measured by growth rate, feed efficiency or egg production. More efficient disease control brings improved yields due to better flock health, increased processing plant efficiency and fewer condemnations.
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global